88IV - PR Newswire Asia's news - Health Care/Hospital

< Previous page

| Title only | Print

Next page >

The Galien Foundation Announces the Nominees for the Inaugural 2026 Prix Galien Korea Awards Historic First Edition Launches in Partnership with MK Media (Maekyung), Yozma Group Korea, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), and KoreaBIO at the World Knowledge ... 2026-09-03T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
AAHRPP Accredits Five More Research Entities 21 more organizations earn reaccreditation ... 2026-09-03T Biotechnology Health Care/Hospital Higher Education Medical/Pharmaceuticals
Ivonescimab Meets Overall Survival Key Secondary Endpoint in Interim Analysis of Phase III HARMONi-2 Study, Demonstrating Statistically Significant and Clinically Meaningful Benefit Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC HONG KONG , Sept. 3, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that a pre-specified interim analysis of overall survival (OS) in the HARMONi-2 ... 2026-09-03T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Helfie AI Appoints John Rego as Chief Financial Officer Veteran CFO with more than $10 billion raised across six public and private companies joins Helfie AI to lead financial strategy ... 2026-09-03T Computer/Electronics Health Care/Hospital
EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction PROVIDENCE, R.I. , Sept. 3, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™ , its proprietary in silico platform for assessing the immunogenicity ... 2026-09-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ocius Technology to Add Sonar Systems to Bluebottle Fleet: NYSE Content Update NYSE issues a pre-market daily advisory direct from the trading floor. ... 2026-09-02T Banking/Financial Service Computer/Electronics Health Care/Hospital
Alteogen Enters Option and License Agreement with Novartis for Development and Commercialization of Hybrozyme™-Enabled Subcutaneous Products Novartis obtains rights to develop and commercialize subcutaneous formulations for multiple products utilizing ALT-B4 Alteogen's fourth licensing agreement signed this year further accelerating the ... 2026-09-02T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury Round led by Neurimmune and Pureos, with participation from existing and new investors; complemented by non-dilutive funding from the Swiss Paraplegic Foundation and Wings for Life - Spinal Cord Research ... 2026-09-02T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Norroy Bioscience Initiates Pivotal Phase III Clinical Trial of 177Lu-NYM032, a PSMA-Targeted Radioligand Therapy for mCRPC WUXI, China , Sept. 2, 2026 /PRNewswire/ -- NORROY BIOSCIENCE (NORROY) , a clinical-stage biotechnology company focused on innovative targeted radiopharmaceuticals, announced that it has received regulatory ... 2026-09-02T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
BTL Establishes New Laser Division and Introduces EXOLASE ONE® - The World's First Fused Erbium Laser Proprietary technology fuses multiple wavelengths into a single beam to set a new standard of care in laser facial rejuvenation. ... 2026-09-02T Computer/Electronics Cosmetics & Personal Care Health Care/Hospital Medical Equipment

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved